Definition

What Is Viral Hepatitis?

Viral hepatitis is liver inflammation caused by one of five distinct hepatitis viruses (A, B, C, D, E). The three most important globally are hepatitis A (acute, foodborne, self-limiting), hepatitis B (can cause acute and chronic infection, vaccine preventable), and hepatitis C (often chronic, but now curable with direct-acting antivirals).

Acute viral hepatitis presents with jaundice, fatigue, nausea, and elevated liver enzymes. Most cases of hepatitis A and many cases of hepatitis B resolve spontaneously. Hepatitis C is asymptomatic in ~80% during acute infection but progresses to chronic infection in ~70-85% of those infected.

Chronic hepatitis B and C are leading causes of cirrhosis and hepatocellular carcinoma globally, together accounting for ~70% of liver cancer cases. Modern antiviral therapy has dramatically changed prognosis: hepatitis C is now curable in >95% of patients with 8-12 weeks of oral DAAs; hepatitis B can be suppressed (though rarely cured)³ with long-term antivirals.

💡 Key Insight: Hepatitis C is curable. If you have any risk factors (born 1945-1965, IV drug history, blood transfusion before 1992, tattoos in unregulated settings), get tested. A simple antibody test followed by RNA confirmation, then 8-12 weeks of direct-acting antivirals (glecaprevir/pibrentasvir, sofosbuvir/velpatasvir, ledipasvir/sofosbuvir, sold as Mavyret, Epclusa and Harvoni) cures the infection.²

The Three Major Hepatitis Viruses

🍽️ Hepatitis A (HAV)

Fecal-oral transmission¹ (contaminated food/water, poor sanitation). Acute illness, no chronic form. Self-limiting in >99%. Vaccine preventable. Common in travelers to endemic areas. Lifelong immunity after infection.

💉 Hepatitis B (HBV)

Blood/sexual/perinatal transmission. ~5% of adults progress to chronic infection (much higher in children/infants). Chronic HBV increases cirrhosis and liver cancer risk. Vaccine preventable. Treatable with antivirals (tenofovir, entecavir).

🩸 Hepatitis C (HCV)

Bloodborne (mainly IV drug use, pre-1992 transfusions). ~70-85% become chronic. NO vaccine yet. CURABLE in >95% with 8-12 weeks of oral DAAs (Mavyret, Epclusa). Major cause of liver cancer historically.

Signs & Symptoms

Symptoms of Viral Hepatitis

Acute hepatitis has characteristic prodrome followed by jaundice. Chronic infections are often asymptomatic until advanced liver disease develops.

🔥 Acute Hepatitis

😴

Profound Fatigue

Often the earliest and most prominent symptom. Severe, disabling. Lasts weeks to months. May persist after biochemical recovery.

🟡

Jaundice

Yellow eyes/skin (sclera first), dark cola-colored urine, pale clay-colored stools. Develops as bilirubin rises. May or may not appear in all cases.

🤢

Anorexia, Nausea, Vomiting

Severe loss of appetite, particularly aversion to fatty foods and cigarettes (in smokers). Nausea and vomiting common. Weight loss.

😣

Right Upper Quadrant Discomfort

Dull ache from inflamed liver stretching its capsule. Not the sharp pain of biliary disease. Hepatomegaly often palpable.

🕰️ Chronic Hepatitis B/C

😶

Often Asymptomatic for Decades

The dangerous reality of chronic HBV and HCV, many patients have NO symptoms until they develop cirrhosis or liver cancer 20-40 years after infection. This is why screening is critical.

😴

Chronic Fatigue

The most common symptom when present. Disproportionate to liver enzyme levels. Significantly impacts quality of life.

🦴

Joint Pain (Arthralgia)

Common with chronic HCV. Polyarthralgia involving small joints. Sometimes precedes other symptoms. May be mistaken for early rheumatoid arthritis.

⚠️

Signs of Advanced Disease (Cirrhosis)

Late presentation: ascites, jaundice, varices, hepatic encephalopathy, palmar erythema, spider angiomas. Indicates progression to cirrhosis, emergent evaluation needed.

Diagnosis

How to Diagnose Viral Hepatitis

🧪 Serologic Diagnosis

🩸 Hepatitis A

Anti-HAV IgM, positive in acute infection. Anti-HAV IgG, positive after recovery or vaccination (immunity). Total Anti-HAV, combination.

🩸 Hepatitis B Panel

HBsAg: active infection (acute or chronic). Anti-HBs: immunity (recovery or vaccine). Anti-HBc IgM: recent infection. Anti-HBc IgG: past or chronic. HBeAg + HBV DNA: viral replication/activity.

🩸 Hepatitis C

Anti-HCV antibody: screening test (positive = ever exposed). HCV RNA (PCR): confirms active infection (positive = currently infected). HCV genotype: guides treatment selection.

📊 Disease Assessment

🩸 Liver Function Tests

AST, ALT (acute: often >1,000; chronic: mildly elevated or normal). Alkaline phosphatase, bilirubin, albumin, INR (synthetic function markers).

📡 FibroScan (Transient Elastography)

Non-invasive measurement of liver stiffness, stages fibrosis. Replaces biopsy in most cases. Critical for chronic HBV/HCV staging.

🧮 FIB-4 & APRI Scores

Blood-based non-invasive fibrosis scores. Use AST, ALT, platelet count, age. Free, accessible, useful first-line.

📡 Ultrasound + AFP (HCC Screening)

Every 6 months for cirrhotic patients or chronic HBV, surveillance for hepatocellular carcinoma. Alpha-fetoprotein blood test paired with imaging.

Treatment Comparison

Holistic vs. Conventional Treatment

🌿 HOLISTIC

💊 CONVENTIONAL

🌿

Holistic / Functional Approach

SUPPORTIVE for acute hepatitis; COMPLEMENTARY for chronic. Hep C should be CURED with DAAs first.

Acute Hepatitis A/B

Supportive, rest, hydration, nutrition; most resolve spontaneously

Chronic Hepatitis B

Antiviral therapy + lifestyle to slow fibrosis. Holistic complements, doesn't replace.

Chronic Hepatitis C

GET CURED with DAAs first (8-12 weeks). Then liver-supportive nutrition for healing.

Liver Regeneration

Antioxidants, milk thistle, NAC support hepatocyte recovery

Liver-Supportive Strategy

Strict alcohol abstinence, non-negotiable. Even moderate drinking accelerates fibrosis dramatically.
Avoid hepatotoxic drugs, limit acetaminophen (<2g/day), avoid unnecessary medications, check drug interactions
Adequate protein, 1-1.5g/kg/day for hepatocyte regeneration (unless severe encephalopathy)
Mediterranean diet, anti-inflammatory, antioxidant-rich, supports liver health
Milk thistle (silymarin)⁵ 600-900mg/day, hepatoprotective antioxidant; modest evidence but well-tolerated
NAC 600-1,800mg/day, glutathione precursor; protects hepatocytes
Alpha-lipoic acid 300-600mg/day, universal antioxidant; regenerates other antioxidants
Vitamin D optimization, deficiency common; aim 40 to 60 ng/mL, the Endocrine Society's preferred range. Improves antiviral response.
Selenium 200mcg/day, antioxidant cofactor; deficient in liver disease
Coffee 2-3 cups/day, strongly associated with reduced fibrosis progression
Vaccinate against HAV + HBV if not already immune, prevents super-infection
HCC surveillance, every 6 months if cirrhotic or chronic HBV. Non-negotiable.

✅ Important: If you have hepatitis C, the most "natural" thing you can do is GET CURED. Modern DAAs are 95%+ effective with minimal side effects. Don't pursue holistic-only approaches for chronic HCV when cure is available. After cure, use holistic strategies for liver healing.

💊

Conventional / Medical Approach

Antiviral therapy curative for HCV; suppressive for HBV; supportive for HAV

Hep A Treatment

Supportive only, rest, hydration. No antiviral. Vaccinate at risk individuals.

Hep B Treatment

Tenofovir, entecavir, suppress virus. Lifelong therapy usually. Vaccine prevents.

Hep C Treatment

DAAs (Mavyret, Epclusa, Harvoni), CURE in 8-12 weeks. >95% success rate.

Cirrhosis Management

Surveillance for HCC + varices; transplant referral if decompensated

Standard Medical Treatment

Hepatitis A: supportive care. Most resolve in 4-8 weeks. Vaccination for prevention (2 doses).
Hepatitis B (chronic): tenofovir alafenamide (Vemlidy) or entecavir, suppress viral replication. Usually lifelong. HBsAg seroconversion is the goal but rarely achieved.
Hepatitis C: direct-acting antivirals, Mavyret (glecaprevir/pibrentasvir, 8 weeks), Epclusa (sofosbuvir/velpatasvir, 12 weeks), Harvoni. CURE rate >95%. Well tolerated.
HBV/HCV co-infection: careful management; HCV cure can reactivate HBV, monitor or treat HBV concurrently
Vaccination: HAV (post-exposure prophylaxis + travelers, at-risk); HBV (universal childhood + adults at risk)
HCC screening: ultrasound + AFP every 6 months in cirrhotic patients and chronic HBV
Endoscopy: variceal screening in cirrhosis
Liver transplant: for decompensated cirrhosis or HCC within Milan criteria

⚠️ Hep C Cure Is Game-Changing: Modern DAA therapy cures hepatitis C in >95% with minimal side effects. If you have HCV, treatment access is the priority, Medicare, Medicaid, and most insurance cover it. Cure prevents cirrhosis, liver cancer, and transmission to others.

Nutritional Strategy

Diet for Liver Healing

Anti-inflammatory, antioxidant-rich diet supports hepatocyte regeneration and slows fibrosis progression. Absolute alcohol abstinence is non-negotiable.

✅ Prioritize:

🥬 Cruciferous & Sulfur-Rich Vegetables

Broccoli, Brussels sprouts, kale, garlic, onions. Cruciferous and allium vegetables support general liver function and are worth eating. The "phase I and phase II detoxification" framing describes real enzyme systems but has not been shown to change the course of viral hepatitis.⁶

☕ Coffee (2-3 cups/day)

Consistently shown to slow fibrosis progression in chronic hepatitis B and C. Reduces liver cancer risk. Black coffee preferred.

🐟 Fatty Fish (Wild Salmon, Sardines)

Omega-3 EPA/DHA reduce hepatic inflammation. 2-3 servings per week. Avoid farmed if possible.

🫐 Berries & Colorful Plants

Polyphenol and flavonoid-rich. Anti-inflammatory and antioxidant. Aim for diverse colors daily.

🥚 Adequate Protein (1-1.5g/kg)

Eggs, fish, poultry, legumes. Liver regeneration requires amino acids. Don't restrict protein unless severe hepatic encephalopathy.

❌ Strictly Avoid:

🚫 Alcohol (ZERO tolerance)

Even small amounts accelerate fibrosis dramatically in viral hepatitis. Alcohol + virus = synergistic liver damage. Complete abstinence required⁴.

🍬 Refined Sugar & Fructose

Drive hepatic steatosis on top of viral hepatitis. Doubly hard on the liver. Eliminate sodas, juices, sweets, HFCS.

🍔 Industrial Seed Oils & Trans Fats

Pro-inflammatory. Worsen oxidative stress in liver. Eliminate canola, corn, soybean oils; replace with olive, avocado, coconut.

💊 Acetaminophen (Caution)

Limit to <2g/day in chronic liver disease. Avoid combining with alcohol ever. Don't exceed labeled doses. Check OTC combination products.

🍣 Raw Shellfish (in HAV areas)

Oysters and clams can transmit hepatitis A. Avoid raw shellfish from waters of unknown safety. Get vaccinated.

Supplement Protocol

Evidence-Based Supplements

Liver-supportive supplements complement but don't replace antiviral therapy. For HCV, prioritize getting cured with DAAs.

Supplement	Mechanism & Evidence	Suggested Dose	Timing	Notes
Milk Thistle (Silymarin)	Antioxidant, anti-fibrotic, hepatocyte membrane stabilizer. Modest but consistent evidence in chronic hepatitis.	600-900mg/day (standardized to 80% silymarin)	Divided doses with meals	Best-studied herb for liver. Choose phosphatidylcholine-bound forms for bioavailability.
N-Acetyl Cysteine (NAC)	Glutathione precursor, replenishes liver's master antioxidant depleted in viral hepatitis.	600-1,800mg/day	Divided doses	Also protects against acetaminophen toxicity.
Alpha-Lipoic Acid	Universal antioxidant; regenerates other antioxidants (vitamin C, E, glutathione). Reduces oxidative liver damage.	300-600mg/day	Empty stomach	R-form better absorbed. May lower blood sugar.
Vitamin D3	Deficiency strongly correlates with chronic hepatitis severity. Improves antiviral response, reduces inflammation.	Test 25-OH-D first and set the dose with your clinician (titrate to 40 to 60 ng/mL, the Endocrine Society's preferred range)	With fat meal	Test baseline level. Pair with K2 200mcg.
Selenium	Cofactor for glutathione peroxidase. Deficient in chronic liver disease. May reduce HCC risk.	200mcg/day	With food	Don't exceed 400mcg/day long-term.
Vitamin E (Mixed Tocopherols)	Antioxidant; some evidence for reducing fibrosis in chronic hepatitis (especially with steatosis).	400-800 IU/day	With fat meal	Use mixed tocopherols, not alpha-tocopherol alone.
Glycyrrhizin (Licorice Root)	Anti-inflammatory, antiviral effects. Used IV in Japan for chronic hepatitis. Reduces ALT levels.	150-300mg/day, and only with a clinician	With meals	Caution: raises blood pressure and lowers potassium, and some people are affected at low intakes. DGL is not a substitute here, because deglycyrrhizinated licorice has the glycyrrhizin removed and cannot produce this effect. Needs blood pressure and potassium monitoring.
Curcumin (Turmeric)	Anti-inflammatory, antifibrotic, hepatoprotective. Reduces oxidative stress in liver.	500-1,500mg/day (with piperine or liposomal)	With fat meal	Standard curcumin poorly absorbed, choose bioavailable forms.

References & Evidence Notes

Each numbered entry below is either a source you can follow or a note setting out what the evidence does and does not support. Both are numbered together so the markers in the text line up.

Last reviewed 27 August 2026. Supplement entries are cross-checked against the NIH National Center for Complementary and Integrative Health and the Linus Pauling Institute Micronutrient Information Center.⁷ The most important thing on this page is short: hepatitis C is curable, in more than 95% of people, with 8 to 12 weeks of well-tolerated oral tablets. If you have it, or might have it, get tested and treated. There is no version of this where a supplement regimen is a reasonable alternative, and the page says so already. Hepatitis B is different: it is usually suppressed rather than cured, treatment is long-term, and stopping antivirals abruptly can cause a dangerous flare, so that is never a self-directed decision. Hepatitis A and B are both vaccine-preventable, and vaccination is recommended for anyone with chronic liver disease. Nutrition supports the liver through and after treatment; it does not clear a virus.

On the three viruses: hepatitis A is faecally transmitted, usually self-limiting and vaccine-preventable. Hepatitis B is blood and body-fluid transmitted, becomes chronic more often when acquired in infancy, is vaccine-preventable, and carries hepatocellular carcinoma risk even without cirrhosis. Hepatitis C is blood-borne, becomes chronic in most people, and is now curable. ↩
On hepatitis C cure. Direct-acting antiviral regimens are reported to achieve sustained virologic response, meaning cure, in over 95% of patients with 8 to 12 weeks of oral therapy, across genotypes and including people with cirrhosis. Cure reduces but does not eliminate hepatocellular carcinoma risk in those with established cirrhosis, so surveillance continues after cure. Reinfection is possible, so ongoing risk reduction still matters. ↩
On hepatitis B, and why stopping treatment is dangerous. Nucleoside and nucleotide analogues suppress viral replication and reduce progression and cancer risk, but rarely eradicate the virus. Discontinuing therapy can precipitate a severe hepatitis flare and hepatic decompensation; severe flares after antiviral withdrawal are documented, PubMed 42019867, and stopping is a decision made and monitored by a specialist. Immunosuppressive treatment, including corticosteroids and rituximab, can reactivate hepatitis B, which is why screening before immunosuppression is standard. ↩
On alcohol: alcohol and chronic viral hepatitis together accelerate fibrosis substantially more than either alone. Abstinence is the single most valuable dietary change during and after treatment. ↩
On milk thistle: silymarin is widely used and generally well tolerated, and it is worth being clear about the evidence. A randomized controlled trial of higher-dose oral silymarin in chronic hepatitis C, published in JAMA in 2012, did not reduce serum ALT compared with placebo. It has not been shown to clear virus or to change disease progression. It is not a reason to delay curative treatment. ↩
On liver-supportive eating: coffee consumption is associated with lower liver enzymes, less fibrosis progression and lower hepatocellular carcinoma risk across multiple cohorts: a meta-analysis found roughly 40% lower hepatocellular carcinoma risk for any coffee consumption versus none, while noting reverse causation may explain part of the association, PubMed 23660416. It is one of the more consistent dietary findings in hepatology. Adequate protein supports regeneration. Avoid iron supplements without documented deficiency, since iron accumulation worsens liver injury. ↩
National Center for Complementary and Integrative Health (NIH), nccih.nih.gov, and the Linus Pauling Institute Micronutrient Information Center, lpi.oregonstate.edu/mic.